| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 26.72B | 26.57B | 27.92B | 29.66B | 31.33B | 26.73B |
| Gross Profit | 6.95B | 6.85B | 6.62B | 7.01B | 6.52B | 6.04B |
| EBITDA | 3.00B | 3.17B | 3.09B | 3.25B | 3.15B | 2.44B |
| Net Income | 2.07B | 2.08B | 2.00B | 2.11B | 2.01B | 1.54B |
Balance Sheet | ||||||
| Total Assets | 30.99B | 33.26B | 32.57B | 31.92B | 31.39B | 31.41B |
| Cash, Cash Equivalents and Short-Term Investments | 4.07B | 5.73B | 4.65B | 5.53B | 4.45B | 4.68B |
| Total Debt | 4.41B | 4.01B | 4.21B | 5.00B | 5.03B | 5.66B |
| Total Liabilities | 9.25B | 11.39B | 11.12B | 11.82B | 12.23B | 13.74B |
| Stockholders Equity | 21.73B | 21.86B | 21.45B | 20.10B | 19.16B | 17.67B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.80B | 660.00M | 2.50B | 821.00M | 694.00M |
| Operating Cash Flow | 0.00 | 2.84B | 717.00M | 2.54B | 886.00M | 887.00M |
| Investing Cash Flow | 0.00 | 140.00M | 25.00M | -206.00M | -5.00M | -415.00M |
| Financing Cash Flow | 0.00 | -1.90B | -1.63B | -1.25B | -1.11B | -73.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | €139.95B | 9.20 | 11.58% | 1.98% | 9.81% | 30.20% | |
74 Outperform | ¥65.97B | 13.75 | ― | 3.22% | 8.89% | 102.20% | |
72 Outperform | ¥17.07B | 8.37 | ― | 4.44% | 2.89% | 16.08% | |
67 Neutral | ¥95.16B | 20.18 | ― | 1.19% | -3.56% | -30.17% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
58 Neutral | $88.11B | 25.61 | 5.78% | 1.38% | 0.82% | -1.72% | |
56 Neutral | ¥39.21B | ― | ― | 9.52% | -35.81% | -138.00% |